Dr. Ho is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3730 S Eastern Ave
Las Vegas, NV 89169Phone+1 702-952-3400Fax+1 702-952-3461
Education & Training
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 2005 - 2008
- University of Illinois College of Medicine at PeoriaResidency, Internal Medicine, 2003 - 2005
- University of Illinois College of Medicine at PeoriaInternship, Internal Medicine, 2002 - 2003
- University of IndonesiaClass of 1998
Certifications & Licensure
- NV State Medical License 2008 - 2025
- IL State Medical License 2002 - 2008
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Efficacy Evaluation of Enobosarm Monotherapy in Treatment of AR+/ER+/HER2- Metastatic Breast Cancer Start of enrollment: 2021 Oct 12
Publications & Presentations
PubMed
- Pregabalin-Induced Bullous Pemphigoid: A Case Report of a Rare Drug-Triggered Autoimmune Skin Disorder.Rachel Tovar, Daniel T Jones, Ramaditya Srinivasmurthy, Meghana Pandit, Liawaty Ho
Cureus. 2024-09-01 - Raoultella ornithinolytica Urinary Tract Infection in a Patient With Triple-Negative Breast Cancer.Daniel T Jones, Ramaditya Srinivasmurthy, Meghana Pandit, Rachel Tovar, Liawaty Ho
Cureus. 2024-07-01 - 46 citationsPhase II study of the proteasome inhibitor bortezomib (PS-341, Velcade) in chemotherapy-naïve patients with advanced stage non-small cell lung cancer (NSCLC).Tianhong Li, Liawaty Ho, Bilal Piperdi, Tarek N. Elrafei, Fernando Camacho
Lung Cancer. 2010-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: